Neural Regeneration Research ›› 2025, Vol. 20 ›› Issue (2): 491-502.doi: 10.4103/NRR.NRR-D-23-01263

Previous Articles     Next Articles

Overexpression of low-density lipoprotein receptor prevents neurotoxic polarization of astrocytes via inhibiting NLRP3 inflammasome activation in experimental ischemic stroke

Shuai Feng1, #, Juanji Li2, #, Tingting Liu1, Shiqi Huang1, Xiangliang Chen1, Shen Liu1, Junshan Zhou1, Hongdong Zhao1, *, Ye Hong1, *   

  1. 1Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China; 2Department of Neurology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province, China
  • Online:2025-02-15 Published:2024-06-18
  • Contact: Hongdong Zhao, MD, redeastzh@126.com; Ye Hong, PhD, hongye19920920@163.com.
  • Supported by:
    This work was supported by the National Natural Science Foundation of China, No. 82201460 (to YH); Nanjing Medical University Science and Technology Development Fund, No. NMUB20210202 (to YH).

Abstract: Neurotoxic astrocytes are a promising therapeutic target for the attenuation of cerebral ischemia/reperfusion injury. Low-density lipoprotein receptor, a classic cholesterol regulatory receptor, has been found to inhibit NLR family pyrin domain containing protein 3 (NLRP3) inflammasome activation in neurons following ischemic stroke and to suppress the activation of microglia and astrocytes in individuals with Alzheimer’s disease. However, little is known about the effects of low-density lipoprotein receptor on astrocytic activation in ischemic stroke. To address this issue in the present study, we examined the mechanisms by which low-density lipoprotein receptor regulates astrocytic polarization in ischemic stroke models. First, we examined low-density lipoprotein receptor expression in astrocytes via immunofluorescence staining and western blotting analysis. We observed significant downregulation of low-density lipoprotein receptor following middle cerebral artery occlusion reperfusion and oxygen–glucose deprivation/reoxygenation. Second, we induced the astrocyte-specific overexpression of low-density lipoprotein receptor using astrocyte-specific adeno-associated virus. Low-density lipoprotein receptor overexpression in astrocytes improved neurological outcomes in middle cerebral artery occlusion mice and reversed neurotoxic astrocytes to create a neuroprotective phenotype. Finally, we found that the overexpression of low-density lipoprotein receptor inhibited NLRP3 inflammasome activation in oxygen–glucose deprivation/reoxygenation injured astrocytes and that the addition of nigericin, an NLRP3 agonist, restored the neurotoxic astrocyte phenotype. These findings suggest that low-density lipoprotein receptor could inhibit the NLRP3-meidiated neurotoxic polarization of astrocytes and that increasing low-density lipoprotein receptor in astrocytes might represent a novel strategy for treating cerebral ischemic stroke.

Key words: inflammation, ischemia/reperfusion injury, ischemic stroke, low-density lipoprotein receptor, neuroprotective astrocytes, neurotoxic astrocytes, NLRP3 inflammasome, polarization